Abstract 4868: Targeting of ERG positive prostate cancers with ERGi-USU-6 salt derivative
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-4868
Abstract: Introduction: Prostate cancer (PCa) is the second leading cause of cancer deaths among men in the United States. Approximately 50% of patients with PCa harbor an oncogenic TMPRRS2- ERG gene fusion in their primary tumor… read more here.
Keywords: ergi usu; prostate; erg positive; salt derivative ... See more keywords
Abstract B062: ERGi-USU selectively inhibit ERG positive prostate cancer through ATF3 mediated ferroptosis
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.prca2023-b062
Abstract: Introduction: Prostate cancer (PCa) is the second leading cause of cancer deaths among men in the United States. Approximately 50% of patients with PCa harbor an oncogenic TMPRRS2- ERG gene fusion in their primary and… read more here.
Keywords: ergi usu; prostate cancer; cancer; erg positive ... See more keywords